The Department of Defense is seeking quotes for pharmaceutical agents to be considered for its Uniform Formulary, with the potential for award of Blanket Purchase Agreements and Additional Discount Program Agreements. A Pharmacy and Therapeutics Committee meeting in February 2026 will review four newly approved drugs for specific therapeutic classes. A pre-quotation teleconference is scheduled for January 14, 2026. Clinical question responses must be submitted via email by a deadline specified within the solicitation documents. The full instructions and points of contact are contained in the attached RFQ.